Content by BioStatus Limited

Well-established assay formats that can be used throughout the development continuum are  a great benefit to researchers

Although there are no universally accepted guidelines to ensure that antibodies have been properly validated, there are steps that can (and should) be taken by both the antibody industry and the researchers who use antibodies to improve that situation

Many in recent years have highlighted unreliability and irreproducibility of much science research, adding up to an estimated $28 billion wasted each year in irreproducible preclinical research in the United States alone and, arguably, the greatest need for change lies in the field of commercial antibodies

When cell-sorting technology first arrived in the late 1970s, it was used by academics and the medical research community to detect, count and characterize cells from the body and environment. As cell-sorting technology evolved and improved, it also became more complex, unfortunately making it less accessible to many researchers. Fortunately, recent advances in instrumentation have led to the development of much smaller, significantly less expensive and much easier-to-use cell-sorting devices, meaning that even basic researchers can now access this useful technology.